CurrentPartnering, March 2012, Pages: 245
worlds leading healthcare companies.
- Trends in cancer vaccine partnering deals
- Disclosed headlines, upfronts, milestones and royalties by stage of development
- Cancer vaccine partnering contract
John Wiley and Sons Ltd, June 2012, Pages: 496
, clients and families, and genetic test results and follow-up. This is the only reference and clinical book on the market for cancer genetics counselors and other healthcare providers who must quickly
TriMark Publications, July 2011, Pages: 267
cancer, some of which are in development for more than one type of the disease, for a total of more than 500 ongoing R&D projects.
The goal of this TriMark Publications report is to review the market for
GlobalData, Dec 2011, Pages: 98
Gallbladder Cancer Global Clinical Trials Review, H2, 2011 Gallbladder Cancer Global Clinical Trials Review, H2, 2011
Summary
GlobalData's clinical trial report, “Gallbladder Cancer Global Clinical
GlobalData, Feb 2012, Pages: 70
competition in the seven key countries Laryngeal Cancer Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a
GlobalData, Jan 2012, Pages: 147
partnerships.
- What’s the next big thing in the global cancer vaccines market landscape? – Identify, understand and capitalize.
Keywords
Pharma, Pharmaceuticals, Healthcare, Deal Value, Deal Volume, Private
GlobalData, Dec 2011, Pages: 84
Oral Cancer Global Clinical Trials Review, H2, 2011 Oral Cancer Global Clinical Trials Review, H2, 2011
Summary
GlobalData's clinical trial report, “Oral Cancer Global Clinical Trials Review, H2
GlobalData, Dec 2011, Pages: 81
Testicular Cancer Global Clinical Trials Review, H2, 2011 Testicular Cancer Global Clinical Trials Review, H2, 2011
Summary
GlobalData's clinical trial report, “Testicular Cancer Global Clinical
GlobalData, Dec 2011, Pages: 128
competition in the seven key countries Cervical Cancer Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a
Global Industry Analysts, Inc., Oct 2011, Pages: 897
Therapies: An Outlook 5
US Retains Global Dominance 5
Immunotherapies Lead the Suite, Targeted Therapies to Claim
the Top Spot 5
Cancer Therapies: A Review 6
Enduring Success of Top Drug Makers Makes
Global Industry Analysts, Inc., Oct 2010, Pages: 360
Comprehensive Review on Radiation Therapy 52
Radiation Therapy, a Panacea for all Cancer Diseases 53
Composition of Radiation Therapy Treatment Team
GlobalData, Jan 2012, Pages: 90
Oropharyngeal Cancer Global Clinical Trials Review, H1, 2012 Oropharyngeal Cancer Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Oropharyngeal Cancer Global
GlobalData, Nov 2011, Pages: 70
Vaginal Cancer Global Clinical Trials Review, H2, 2011 Vaginal Cancer Global Clinical Trials Review, H2, 2011
Summary
GlobalData's clinical trial report, “Vaginal Cancer Global Clinical Trials
BioPharm Reports (VennBio Ltd.), Jan 2009, Pages: 235
Cancer Drug Resistance Drug resistance is the single most important cause of cancer treatment failure and carries a massive burden to patients, healthcare providers, drug developers and society. It
Global Industry Analysts, Inc., Oct 2011, Pages: 323
Installed Base for Hologic, GE
Healthcare, and Others (includes corresponding
Graph/Chart) 88
Breast Cancer Cases in the US 89
Table 36: Probability of Developing Invasive Breast Cancer
by Age Group in
GlobalData, Jan 2012, Pages: 78
Vulvar Cancer Global Clinical Trials Review, H1, 2012 Vulvar Cancer Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Vulvar Cancer Global Clinical Trials Review
GlobalData, Jan 2012, Pages: 53
Penile Cancer Global Clinical Trials Review, H1, 2012 Penile Cancer Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Penile Cancer Global Clinical Trials Review
Global Industry Analysts, Inc., Feb 2010, Pages: 220
Review II-5
Continuous Fight Against Cancer: A Key Propeller for Growth II-5
Population Aging Makes Rise Of Cancer Diagnostics Inevitable II-5
Table 3: Probability of Developing Breast Cancer by Age
